Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

207
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
207
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

100
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
100
Hepatic Drug Excretion: Enterohepatic Cycling01:17

Hepatic Drug Excretion: Enterohepatic Cycling

1.6K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
1.6K
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence of a Composite Outcome to Capture Child and Liver Health One Year After Pediatric Liver Transplantation in the Starzl Network.

Pediatric transplantation·2026
Same author

Revisiting POWER in the GLP-1 Age.

Gastroenterology·2026
Same author

The incidence, frequency of late liver-related complications, and transplant likelihood in pediatric acute liver failure in Californian children.

Hepatology communications·2026
Same author

What's New in Pediatric Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis.

Clinics in liver disease·2026
Same author

Demographic Factors and Biliary Atresia: A Childhood Liver Disease Research Network Study.

Pediatrics·2026
Same author

Polyfluoroalkyl substances and altered glucose homeostasis in adolescents following bariatric surgery.

Environmental endocrinology (Oxford, England)·2026

Related Experiment Video

Updated: Jul 26, 2025

Early Pathological and Magnetic Resonance Detection of Cerebral Injury Using a Rat Model of Neonatal Hypoxic Ischemic Encephalopathy
05:52

Early Pathological and Magnetic Resonance Detection of Cerebral Injury Using a Rat Model of Neonatal Hypoxic Ischemic Encephalopathy

Published on: October 28, 2022

818

Hepatic Encephalopathy in Children.

Johanna Ascher Bartlett1, Rohit Kohli2

  • 1Department of Gastroenterology, Hepatology and Nutrition at Children's Hospital Los Angeles, 4650 Sunset Blvd, MS 78, Los Angeles, CA, 90027, USA. jascherbartlett@chla.usc.edu.

Indian Journal of Pediatrics
|June 13, 2023
PubMed
Summary

Hepatic encephalopathy (HE) in children involves mental status changes and requires careful assessment. Early detection and management of HE, including reducing ammonia levels, are crucial for preventing serious complications.

Keywords:
CirrhosisEncephalopathyLiver failurePediatrics

More Related Videos

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

11.4K
The Hypoxic Ischemic Encephalopathy Model of Perinatal Ischemia
08:47

The Hypoxic Ischemic Encephalopathy Model of Perinatal Ischemia

Published on: November 19, 2008

35.8K

Related Experiment Videos

Last Updated: Jul 26, 2025

Early Pathological and Magnetic Resonance Detection of Cerebral Injury Using a Rat Model of Neonatal Hypoxic Ischemic Encephalopathy
05:52

Early Pathological and Magnetic Resonance Detection of Cerebral Injury Using a Rat Model of Neonatal Hypoxic Ischemic Encephalopathy

Published on: October 28, 2022

818
Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

11.4K
The Hypoxic Ischemic Encephalopathy Model of Perinatal Ischemia
08:47

The Hypoxic Ischemic Encephalopathy Model of Perinatal Ischemia

Published on: November 19, 2008

35.8K

Area of Science:

  • Hepatology
  • Pediatric Gastroenterology
  • Neuroscience

Background:

  • Hepatic encephalopathy (HE) presents with mental status and neuropsychiatric changes in chronic and acute liver disease.
  • Clinical manifestations of HE in children can be subtle, making early diagnosis challenging.
  • Progression of HE symptoms may signal cerebral edema and systemic deterioration.

Purpose of the Study:

  • To highlight the importance of assessing hepatic encephalopathy in pediatric patients.
  • To discuss current and emerging diagnostic methods for HE.
  • To outline current treatment strategies for HE.

Main Methods:

  • Review of clinical manifestations and diagnostic challenges of HE in children.
  • Discussion of established and investigational assessment tools (imaging, EEG, neurobiomarkers).
  • Analysis of current therapeutic interventions for HE.

Main Results:

  • Hyperammonemia can be present in HE, but its level does not correlate with clinical severity.
  • Newer diagnostic modalities are under investigation.
  • Treatment focuses on the underlying liver disease and ammonia reduction.

Conclusions:

  • Prompt recognition and management of HE in children are critical.
  • Multifaceted treatment approaches, including medications and liver support, are employed.
  • Ongoing research aims to improve HE diagnosis and treatment.